Work

On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial

Year: 2024

Type: article

Source: Pediatric Research

DOI: 10.1038/s41390-024-03709-z

Authors: Adam Frymoyer, Ana Gabriela Vasconcelos, Sandra E. Juul, Bryan A. Comstock, Patrick J. Heagerty, Yvonne W. Wu

Institutions: Stanford University, University of Washington, University of California, San Francisco

Language: English

Topic: Neonatal and fetal brain pathology

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Neurological Disorders and Stroke

Awards: High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) DCC, High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC

OpenAlex ID: W4404209836

FWCI: 1.212

Cites: 37

Cited by: 2

Related to: 10